Nasus Pharma Ltd (NSRX) stock
NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
$2.87+0.05 (+1.77%)
Close on Nov 13, 2026Market cap $25.87MP/E –Yield –
Nasus Pharma cash
Cash and short-term investments held at the end of each period.
Nasus Pharma's cash was $7.82M at Jun 30, 2026. For fiscal 2025 it was $1.24M, up 335.6% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24M | +335.6% |
| FY2024 | Dec 31, 2024 | $284.00K | +47.2% |
| FY2023 | Dec 31, 2023 | $193.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.82M | +768.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.24M | +540.9% |
| Q2 FY2025 | Jun 30, 2025 | $203.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $284.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $900.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $193.00K | – |
See a number that looks wrong?